Immune Checkpoint Inhibitors Market by Type (CTLA-4 Inhibitor, PD-1 Inhibitor, and PD-L1 Inhibitor) and Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Market: Pharmaceuticals

, 149 pages report, published by Allied Market Research

Report ThumbnailSeptember-2018
The global immune checkpoint inhibitors market was valued at $10,540 million in 2017, and is projected to reach $65,427 million by 2025, registering a CAGR of 25.6% from 2018 to 2025.

Checkpoint inhibitor is a type of drug used in immunotherapy, which helps block the proteins present on tumor cells, as these affect the functioning of the immune system. Immune checkpoint inhibitor drugs block different checkpoint proteins, including cytotoxic T lymphocyte associated protein 4 (CTLA-4), programme

Read More
  • FIGURE 01. IMMUNE CHECKPOINT INHIBITORS MARKET SEGMENTATION
  • FIGURE 02. TOP INVESTMENT POCKETS
  • FIGURE 03. TOP PLAYER POSITIONING, 2017
  • FIGURE 04. WORLD POPULATION AGED 65 AND OVER (%)
  • FIGURE 05. IMPACT ANALYSES
  • FIGURE 06. U.S. IMMUNE CHECKPOINT INHIBITORS MARKET, 2017-2025 ($MILLION)
  • FIGURE 07. CANADA IMMUNE CHECKPOINT INHIBITORS MARKET, 2017-2025 ($MILLION)
  • FIGURE 08. MEXICO IMMUNE CHECKPOINT INHIBITORS MARKET, 2017-2025 ($MILLION)
  • FIGURE 09. GERMANY IMMUNE CHECKPOINT INHIBITORS MARKET, 2017-202
Read More
  • TABLE 01. CLINICAL TRIALS IN IMMUNE CHECKPOINT INHIBITORS MARKET, 2015-2018
  • TABLE 02. PRODUCT PIPELINE ANALYSIS (PHASE II & III)
  • TABLE 03. GLOBAL IMMUNE CHECKPOINT INHIBITORS MARKET, BY TYPE, 2017-2025 ($MILLION)
  • TABLE 04. CTLA-4 INHIBITOR MARKET, BY REGION, 2017-2025 ($MILLION)
  • TABLE 05. PD-1 INHIBITOR MARKET, BY REGION, 2017-2025 ($MILLION)
  • TABLE 06. PD-L1 INHIBITOR MARKET, BY REGION, 2017-2025 ($MILLION)
  • TABLE 07. GLOBAL IMMUNE CHECKPOINT INHIBITORS MARKET, BY APPLICATION, 2017-2025 ($MILLION
Read More
  • CHAPTER 1: INTRODUCTION
  • 1.1. Report description
  • 1.2. Key benefits for stakeholders
  • 1.3. Key market segments
  • 1.3.1. List of key players profiled in the report
  • 1.4. Research methodology
  • 1.4.1. Secondary research
  • 1.4.2. Primary research
  • 1.4.3. Analyst tools and models
  • CHAPTER 2: EXECUTIVE SUMMARY
  • 2.1. Key findings of the study
  • 2.1.1. CXO perspective
  • CHAPTER 3: MARKET OVERVIEW
  • 3.1. Market definition and scope
  • 3.2. Key findings
  • 3.2.1. Top investment pockets
  • 3.2.2. Top player positioning
  • 3.
Read More
  • According to a new report published by Allied Market Research, titled, Immune Checkpoint Inhibitors Market, by Type and Application: Global Opportunity Analysis and Industry Forecast, 2018-2025," the global immune checkpoint inhibitors market was valued at $10,540 million in 2017, and is expected to reach $65,427 million by 2025, growing at a CAGR of 25.6% from 2018 to 2025.

    Immune checkpoint inhibitor targets checkpoint proteins and assists the immune system to recognize and attack cancer cell
Read More

Related Products

Allied Market ResearchImmune Checkpoint Inhibitors Market by Type (CTLA-4 Inhibitor, PD-1 Inhibitor, and PD-L1 Inhibitor) and Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025 Product ThumbnailImmune Checkpoint Inhibitors Market by Type (CTLA-4 Inhibitor, PD-1 Inhibitor, and PD-L1 Inhibitor) and Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025 , Industry ReportProduct #: 1194873
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2020 Global Market Analyst. All Rights Reserved